ClearPoint Neuro (CLPT) EPS (Weighted Average and Diluted) (2021 - 2025)
Historic EPS (Weighted Average and Diluted) for ClearPoint Neuro (CLPT) over the last 10 years, with Q3 2025 value amounting to -$0.21.
- ClearPoint Neuro's EPS (Weighted Average and Diluted) fell 1666.67% to -$0.21 in Q3 2025 from the same period last year, while for Sep 2025 it was -$0.84, marking a year-over-year decrease of 2173.91%. This contributed to the annual value of -$0.73 for FY2024, which is 1882.4% up from last year.
- As of Q3 2025, ClearPoint Neuro's EPS (Weighted Average and Diluted) stood at -$0.21, which was down 1666.67% from -$0.21 recorded in Q2 2025.
- In the past 5 years, ClearPoint Neuro's EPS (Weighted Average and Diluted) ranged from a high of -$0.13 in Q1 2021 and a low of -$0.29 during Q2 2023
- For the 5-year period, ClearPoint Neuro's EPS (Weighted Average and Diluted) averaged around -$0.19, with its median value being -$0.18 (2022).
- As far as peak fluctuations go, ClearPoint Neuro's EPS (Weighted Average and Diluted) tumbled by 6111.11% in 2023, and later surged by 4482.76% in 2024.
- Quarter analysis of 5 years shows ClearPoint Neuro's EPS (Weighted Average and Diluted) stood at -$0.19 in 2021, then increased by 2.73% to -$0.18 in 2022, then fell by 2.81% to -$0.19 in 2023, then fell by 9.98% to -$0.21 in 2024, then fell by 0.49% to -$0.21 in 2025.
- Its EPS (Weighted Average and Diluted) stands at -$0.21 for Q3 2025, versus -$0.21 for Q2 2025 and -$0.22 for Q1 2025.